154 related articles for article (PubMed ID: 31541339)
1. Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
Bösch F; Todorova R; Link H; Westphalen CB; Boeck S; Heinemann V; Werner J; Kirchner T; Angele MK; Neumann J
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2689-2697. PubMed ID: 31541339
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry - Correlation with clinical parameters.
Pretzsch E; Bösch F; Todorova R; Nieß H; Jacob S; Guba M; Kirchner T; Werner J; Klauschen F; Angele MK; Neumann J
Pathol Res Pract; 2022 Mar; 231():153797. PubMed ID: 35151032
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
[TBL] [Abstract][Full Text] [Related]
6. Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer.
Dislich B; Blaser N; Berger MD; Gloor B; Langer R
Histopathology; 2020 Apr; 76(5):740-747. PubMed ID: 31898331
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Betge J; Pollheimer MJ; Schlemmer A; Hoefler G; Langner C
Oncol Rep; 2011 Sep; 26(3):567-75. PubMed ID: 21687951
[TBL] [Abstract][Full Text] [Related]
8. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.
Deveci MS; Deveci G
Gastric Cancer; 2007; 10(2):112-6. PubMed ID: 17577621
[TBL] [Abstract][Full Text] [Related]
11. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
12. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
[TBL] [Abstract][Full Text] [Related]
13. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
14. [Pathological Types,Expression of Mismatch Repair Protein,Human Epidermal Growth Factor Receptor 2,and Pan-TRK,and Eostein-Barr Virus Infection in Patients With Colorectal Cancer Resected in Tibet].
Luo HH; Huo Z; BIANbazhaxi ; Wang Q; DUObula ; NImazhuoma ; DA Z; Guo PP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):422-428. PubMed ID: 37407529
[TBL] [Abstract][Full Text] [Related]
15. Impact of extranodal extension on prognosis in lymph node-positive gastric cancer.
Lee IS; Park YS; Ryu MH; Song MJ; Yook JH; Oh ST; Kim BS
Br J Surg; 2014 Nov; 101(12):1576-84. PubMed ID: 25223244
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
18. Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
Link H; Angele M; Schüller M; Ganschow P; Machetanz L; Guba M; Werner J; Kirchner T; Neumann J
BMC Cancer; 2018 Apr; 18(1):483. PubMed ID: 29703178
[TBL] [Abstract][Full Text] [Related]
19. Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma.
Choi JH; Shin NR; Moon HJ; Kwon CH; Kim GH; Song GA; Jeon TY; Kim DH; Kim DH; Park DY
Histol Histopathol; 2012 Nov; 27(11):1439-48. PubMed ID: 23018243
[TBL] [Abstract][Full Text] [Related]
20. Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.
Wang YW; Zhu ML; Wang RF; Xue WJ; Zhu XR; Wang LF; Zheng LZ
Tumour Biol; 2016 Jul; 37(7):8567-78. PubMed ID: 26733174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
